BioWorld
-
Sanofi expands protein degrader ambitions with $2.15B Kymera deal
-
HER2-fore undisclosed: Zymeworks mum on ZW-49 as Merck, BMS deals widen
-
Forbion eyeing late-stage opportunities with $208M fund
-
Today's news in brief
-
Liver protein improves brain function after exercise, but remember Ember
-
Mylan gets remdesivir approval for COVID-19 in India
-
Zai Lab to develop Turning Point drug for NSCLC in China
-
Fosun Kite secures $20M to accelerate first CAR T therapy launch in China
-
CD38 Special: Sanofi caught up in Kiadis, as much as $991M Fated
BioWorld MedTech
-
Philips, Biointellisense partner on at-home patient wearable to monitor COVID, chronic disease
-
Real-world data coming into its own despite bad reputation in times gone by
-
Today's news in brief
-
Virtual reality shows promise in treating chronic pain
-
Hong Kong’s med-tech sector looks to leverage technology, funding to expand
-
BioWorld MedTech’s Diagnostics Extra for July 9, 2020
-
Reflexion, Telix Pharmaceuticals to collaborate to treat high-risk cancers
-
Doctor On Demand raises $75M in series D
-
U.S. FDA urges test developers to amend EUAs for pooled sample testing
BioWorld Asia
-
Japan’s MLWH ends June with string of approvals, looks set for busy 2H 2020
-
SK Biopharma continues to glow after successful listing
-
News in brief
-
HKEX gains Ocumension as its fifth biotech IPO this year
-
COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable’
-
Snowballing research preps avalanche to bury COVID-19
-
Carmine inks $900M+ deal to develop nonviral gene therapies for Takeda
-
Immunotech plans to raise $142M on HKEX to advance AAL therapy for liver cancer
-
Denovo closes $83.5M series C round to support phase III trials of enzastaurin
